SNCA and Parkinson disease: Parkinson’s disease (PD) is a complex neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons, predominantly in the Substantia Nigra pars compacta (SNpc), accompanied by the presence of Lewy bodies (LBs), which are fibrillar aggregates primarily composed of alpha-synuclein.